mitotane has been researched along with Canine Diseases in 68 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 9.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "By treatment with Mitotane in a dose aiming at completely destroying the adrenal cortex, a complete disappearance of the tumor as well as a dramatic reduction of the size of the metastases could be achieved." | 5.30 | [Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report]. ( Flückiger, M; Gardelle, O; Keiser, M; Reusch, C, 1999) |
| "The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges." | 5.11 | Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. ( Frank, LA; Hnilica, KA; Oliver, JW, 2004) |
| "To evaluate urine protein content in dogs with pituitary-dependent hyperadrenocorticism (PDHAC) and to determine the effect of mitotane administration on proteinuria in these dogs." | 3.70 | Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism. ( Hurley, KJ; Vaden, SL, 1998) |
| "Thirty-two dogs with hyperadrenocorticism caused by cortisol-secreting adrenocortical neoplasia were treated with mitotane at an initial daily induction dosage of 27." | 2.67 | Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. ( Kintzer, PP; Peterson, ME, 1994) |
| "Pituitary-dependent hyperadrenocorticism is a common endocrine disorder in dogs in the United States." | 2.44 | Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane. ( Reine, NJ, 2007) |
| "In untreated hyperadrenocorticism, clinical problems may result from metastasis of an adrenocortical carcinoma, growth of a pituitary tumor, or complications associated with sustained hypercortisolemia itself, such as hypertension, cardiovascular disease, thromboembolism, glucose intolerance, and increased susceptibility to infection." | 2.40 | Complications and concurrent disease associated with canine hyperadrenocorticism. ( Nichols, R, 1997) |
| "To describe a case of spontaneous pneumothorax secondary to pulmonary thromboembolism possibly associated with pituitary dependent hyperadrenocorticism." | 1.35 | Pneumothorax secondary to pulmonary thromboembolism in a dog. ( Sobel, KE; Williams, JE, 2009) |
| "Treatment with mitotane was instituted and successful for a period of 4-months until the dog was euthanatized for neurologic problems that were most likely unrelated to endocrine disease." | 1.33 | Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog. ( Behrend, EN; Kemppainen, RJ; Refsal, KR; Weigand, CM; Whitley, EM; Young, DW, 2005) |
| "Multiple endocrine neoplasia type 1 was diagnosed in a 12-year-old male crossbred dog." | 1.31 | Multiple endocrine neoplasia type 1 in a crossbred dog. ( Alley, MR; Burbidge, HM; Guildford, WG; Jones, BR; Walker, MC, 2000) |
| " After successful initial treatment metabolic control deteriorated although insulin dosage was increased." | 1.30 | [Case presentation in small animal medicine]. ( Gfeller, G; Reusch, C, 1998) |
| "By treatment with Mitotane in a dose aiming at completely destroying the adrenal cortex, a complete disappearance of the tumor as well as a dramatic reduction of the size of the metastases could be achieved." | 1.30 | [Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report]. ( Flückiger, M; Gardelle, O; Keiser, M; Reusch, C, 1999) |
| "61 Lysodren -treated dogs with hyperadrenocorticism are compared with 36 untreated dogs with the same disease." | 1.28 | [Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free Un ( Nothelfer, HB; Weinhold, K, 1992) |
| " By lowering the dosage of o,p'-DDD and supplementing with glucocorticoids during the o,p'-DDD loading period, serious hypoglycemia was avoided." | 1.26 | Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs. ( Nesbitt, GH; Peterson, ME; Schaer, M, 1981) |
| "Hyperadrenocorticism was diagnosed in 8 dogs by evaluation of urinary 17-hydroxycorticosteroid (OHCS) excretion rates, urinary 17-OHCS and plasma 11beta-OHCS RESPONSES TO DEXAMETHASONE SUPPRESSION OF ENDOGENOUS ADRENOCORTICOTROPIN (ACTH) secretion, and plasma 11beta-OHCS response to intravenous administration of ACTH." | 1.26 | Gamma camera imaging of bilateral adrenocortical hyperplasia and adrenal tumors in the dog. ( de Bruijne, JJ; Lubberink, AA; Mulnix, JA; Rijnberk, A; Van den Brom, WE, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (32.35) | 18.7374 |
| 1990's | 29 (42.65) | 18.2507 |
| 2000's | 13 (19.12) | 29.6817 |
| 2010's | 2 (2.94) | 24.3611 |
| 2020's | 2 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Golinelli, S | 1 |
| Fracassi, F | 1 |
| Bianchi, E | 1 |
| Pöppl, ÁG | 1 |
| Miceli, DD | 1 |
| Benedicenti, L | 1 |
| De Marco, V | 1 |
| Cook, AK | 1 |
| Espada Castro, L | 1 |
| Ramsey, I | 1 |
| Seo, KW | 1 |
| Cantile, C | 1 |
| Gandini, G | 1 |
| Hulsebosch, SE | 1 |
| Feldman, EC | 7 |
| Park, SM | 1 |
| Kim, KB | 1 |
| Song, WJ | 1 |
| Youn, HY | 1 |
| Griffies, JD | 1 |
| Aldridge, C | 1 |
| Behrend, EN | 3 |
| Kemppainen, RJ | 3 |
| Lee-Fowler, TM | 1 |
| Martin, LG | 1 |
| Ward, CR | 1 |
| Bruyette, D | 1 |
| Pannu, J | 1 |
| Gaillard, P | 1 |
| Lee, HP | 1 |
| Mitchell, CW | 1 |
| Sobel, KE | 1 |
| Williams, JE | 1 |
| Goy-Thollot, I | 1 |
| Péchereau, D | 1 |
| Kéroack, S | 1 |
| Dezempte, JC | 1 |
| Bonnet, JM | 1 |
| Frank, LA | 1 |
| Hnilica, KA | 1 |
| Oliver, JW | 2 |
| Weigand, CM | 1 |
| Whitley, EM | 1 |
| Refsal, KR | 1 |
| Young, DW | 1 |
| Lee, YM | 1 |
| Kang, BT | 1 |
| Jung, DI | 1 |
| Park, C | 1 |
| Kim, HJ | 1 |
| Kim, JW | 1 |
| Lim, CY | 1 |
| Park, EH | 1 |
| Park, HM | 1 |
| Reine, NJ | 1 |
| Brown, CG | 1 |
| Graves, TK | 1 |
| Clemente, M | 1 |
| De Andrés, PJ | 1 |
| Arenas, C | 1 |
| Melián, C | 1 |
| Morales, M | 1 |
| Pérez-Alenza, MD | 1 |
| Peterson, ME | 10 |
| Kaufman, J | 1 |
| Altszuler, N | 1 |
| Nichols, CE | 1 |
| Opitz, M | 2 |
| Lettow, E | 2 |
| Loppnow, H | 2 |
| Grevel, V | 2 |
| Nesbitt, GH | 1 |
| Schaer, M | 1 |
| Willard, MD | 1 |
| Schall, WD | 1 |
| Nachreiner, RF | 2 |
| Shelton, DG | 1 |
| Watson, AD | 2 |
| Kintzer, PP | 4 |
| Nichols, R | 3 |
| Gingerich, DA | 1 |
| Dunn, KJ | 1 |
| Herrtage, ME | 1 |
| Dunn, JK | 1 |
| Bertoy, EH | 1 |
| Nelson, RW | 5 |
| Dublin, AB | 1 |
| Reid, MH | 1 |
| Feldman, MS | 3 |
| Ihle, SL | 2 |
| Guptill, L | 1 |
| Scott-Moncrieff, JC | 2 |
| Bottoms, G | 1 |
| Glickman, L | 1 |
| Johnson, M | 1 |
| Glickman, N | 1 |
| Nelson, R | 1 |
| Bertoy, E | 1 |
| Angles, JM | 1 |
| Hurley, KJ | 1 |
| Vaden, SL | 1 |
| Randolph, JF | 1 |
| Toomey, J | 1 |
| Center, SA | 1 |
| Scarlett, JM | 1 |
| Reimers, T | 1 |
| Graham, P | 1 |
| Bennett, PF | 1 |
| Norman, EJ | 1 |
| Théon, AP | 1 |
| Gfeller, G | 1 |
| Reusch, C | 4 |
| Swinney, GR | 1 |
| Malik, R | 1 |
| den Hertog, E | 1 |
| Braakman, JC | 1 |
| Teske, E | 1 |
| Kooistra, HS | 1 |
| Rijnberk, A | 5 |
| Hörauf, A | 1 |
| Keiser, M | 1 |
| Flückiger, M | 1 |
| Gardelle, O | 1 |
| Clark, TP | 1 |
| Salman, MD | 1 |
| Walker, MC | 1 |
| Jones, BR | 1 |
| Guildford, WG | 1 |
| Burbidge, HM | 1 |
| Alley, MR | 1 |
| Syme, HM | 1 |
| Treadwell, NG | 1 |
| Thompson, MF | 1 |
| Snyder, PW | 1 |
| White, MR | 1 |
| Laus, JL | 1 |
| dos Santos, C | 1 |
| Talieri, IC | 1 |
| Oriá, AP | 1 |
| Bechara, GH | 1 |
| Owens, JM | 1 |
| Drucker, WD | 1 |
| Austin, VH | 1 |
| Ling, GV | 1 |
| Lowenstine, LJ | 1 |
| Pulley, LT | 1 |
| Kaneko, JJ | 1 |
| Chastain, CB | 1 |
| Nash, AS | 1 |
| Bogan, JA | 1 |
| Kelly, DF | 1 |
| Darke, PG | 1 |
| Lavelle, RB | 1 |
| Mulnix, JA | 1 |
| Van den Brom, WE | 1 |
| Lubberink, AA | 1 |
| de Bruijne, JJ | 1 |
| Farver, TB | 1 |
| Nothelfer, HB | 1 |
| Weinhold, K | 1 |
| Voorhout, G | 1 |
| Mol, JA | 1 |
| Hähnle, B | 1 |
| Simpson, JW | 1 |
| van den Broek, AH | 2 |
| Lida, J | 1 |
| Dow, SW | 1 |
| Olson, PN | 1 |
| Rosychuk, RA | 1 |
| Withrow, SJ | 1 |
| Shinsako, J | 1 |
| Belshaw, BE | 1 |
| Moolenaar, AJ | 1 |
14 reviews available for mitotane and Canine Diseases
| Article | Year |
|---|---|
Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Dihydrotestosterone; Dog Dis | 2007 |
Hyperadrenocorticism: treating dogs.
Topics: Adrenal Cortex Function Tests; Adrenalectomy; Adrenocortical Hyperfunction; Animals; Dihydrotestoste | 2007 |
Hyperadrenocorticism.
Topics: Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Animals; Cushi | 1984 |
Diseases of the adrenal cortex of dogs and cats.
Topics: Adrenocorticotropic Hormone; Animals; Cat Diseases; Cats; Cushing Syndrome; Dexamethasone; Disease S | 1984 |
Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Topics: Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dog Diseases; Dogs; Drug Administration Sc | 1994 |
Concurrent illness and complications associated with canine hyperadrenocorticism.
Topics: Acute Disease; Animals; Cushing Syndrome; Diabetes Complications; Diabetes Mellitus; Dog Diseases; D | 1994 |
Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
Topics: Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Dia | 1997 |
Pituitary corticotroph macrotumors. Diagnosis and treatment.
Topics: Adenoma; Animals; Bromocriptine; Dog Diseases; Dogs; Dopamine Agonists; Mitotane; Monoamine Oxidase | 1997 |
Diagnosis and management of canine cortisol-secreting adrenal tumors.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antifungal A | 1997 |
Complications and concurrent disease associated with canine hyperadrenocorticism.
Topics: Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Animals; Antineoplastic Agents; Diabetes Comp | 1997 |
Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
Topics: Animals; Antifungal Agents; Cushing Syndrome; Dog Diseases; Dogs; Dose-Response Relationship, Drug; | 2001 |
Hyperadrenocorticism in the dog: canine Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adrenal | 1977 |
Cushing's syndrome in the dog.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Animals; Calcinosis; Cu | 1976 |
Problems associated with medical therapy of canine hyperadrenocorticism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Animals; Cushing Syndrome; Diabetes Mellitus | 1990 |
5 trials available for mitotane and Canine Diseases
| Article | Year |
|---|---|
Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents; Case-Cont | 2016 |
Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alopecia; Androstenedion | 2004 |
Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone | 1994 |
Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents, Hormonal; | 1998 |
Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenal Glands; Animals; Anorexia; Antineoplastic Agents, Hormonal; Body Weight; Cushing Syndrome; D | 1999 |
49 other studies available for mitotane and Canine Diseases
| Article | Year |
|---|---|
Clinical features of muscle stiffness in 37 dogs with concurrent naturally occurring hypercortisolism.
Topics: Animals; Cushing Syndrome; Dog Diseases; Dogs; Mitotane; Muscles; Pituitary ACTH Hypersecretion | 2023 |
Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents; Dihydrotestosterone; Dog Diseases; Dog | 2021 |
Old or new? A comparison of mitotane and trilostane for the management of hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Dihydrotestosterone; Dog Dis | 2013 |
The imaging diagnosis of pulmonary thromboembolism.
Topics: Animals; Diagnosis, Differential; Dog Diseases; Dogs; Echocardiography; Fatal Outcome; Heart Failure | 2009 |
Pneumothorax secondary to pulmonary thromboembolism in a dog.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Blood Coagulation; Dog Disea | 2009 |
Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; Animals; Antineoplastic Agen | 2002 |
Corticosterone- and aldosterone-secreting adrenocortical tumor in a dog.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Animals; Antineoplastic Agents, Hormonal; Corticosterone; Dog | 2005 |
A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Topics: Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineo | 2005 |
Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Age Factors; Animals; Antineoplastic Agents, Hormonal; Body Weight; Di | 2007 |
o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
Topics: Adrenocorticotropic Hormone; Animals; Cortisone; Cushing Syndrome; Diabetes Complications; Diabetes | 1983 |
Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism.
Topics: Adrenalectomy; Adrenocortical Hyperfunction; Animals; Blood Glucose; Dog Diseases; Dogs; Female; Glu | 1984 |
[Experiences with Lysodren therapy of Cushing's syndrome in the dog (1)].
Topics: Animals; Cushing Syndrome; Dog Diseases; Dogs; Female; Male; Mitotane | 1983 |
[Experiences with Lysodren treatment of Cushing's syndrome in dogs].
Topics: Adrenal Insufficiency; Animals; Central Nervous System Diseases; Cushing Syndrome; Dog Diseases; Dog | 1983 |
Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs.
Topics: Animals; Cushing Syndrome; Diabetes Mellitus; Dog Diseases; Dogs; Female; Insulin; Male; Mitotane | 1981 |
Hypoadrenocorticism following therapy with o,p-DDD for hyperadrenocorticism in four dogs.
Topics: Addison Disease; Animals; Cushing Syndrome; Dog Diseases; Dogs; Female; Male; Mitotane | 1982 |
Comments on use of mitotane.
Topics: Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Mitotane | 1995 |
Increased approvals--myth or reality.
Topics: Animals; Animals, Domestic; Cushing Syndrome; Dog Diseases; Dogs; Drug Approval; Drug Labeling; Legi | 1993 |
Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotropic Hor | 1995 |
One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Female; | 1996 |
Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Creatinine; Dog Diseases; Do | 1997 |
Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Topics: Adrenal Cortex; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic A | 1997 |
Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Female; | 1998 |
Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents, Hormonal; | 1998 |
Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
Topics: Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenocortical Hyperfunctio | 1998 |
[Case presentation in small animal medicine].
Topics: Animals; Antineoplastic Agents, Hormonal; Cushing Syndrome; Diabetes Complications; Diabetes Mellitu | 1998 |
Intermittent heart block in a lethargic dog.
Topics: Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Electrocardiog | 1998 |
[Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
Topics: Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Cushing Syndrome; Dog Diseases; Dogs; Fema | 1999 |
[Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report].
Topics: Adrenal Cortex Neoplasms; Animals; Antineoplastic Agents, Hormonal; Carcinoma; Cushing Syndrome; Dog | 1999 |
Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; | 1999 |
Multiple endocrine neoplasia type 1 in a crossbred dog.
Topics: Adenoma; Animals; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Dog Diseases; Dogs; Male | 2000 |
Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adrenocortical Hyperfunction; Adr | 2001 |
Combined corneal lipid and calcium degeneration in a dog with hyperadrenocorticism: a case report.
Topics: Adrenocortical Hyperfunction; Animals; Antineoplastic Agents, Hormonal; Calcinosis; Corneal Diseases | 2002 |
Selected case reports in small animal dermatology.
Topics: Alopecia Areata; Animals; Calcinosis; Cat Diseases; Cats; Dermatitis; Dog Diseases; Dogs; Epinephrin | 1975 |
Diabetes mellitus in dogs: a review of initial evaluation, immediate and long-term management, and outcome.
Topics: Amylases; Animals; Anorexia; Bicarbonates; Blood Glucose; Blood Urea Nitrogen; Cushing Syndrome; Deh | 1977 |
Hair chewing associated with suspected hyperadrenocorticism in a dog.
Topics: Adrenocortical Hyperfunction; Animals; Behavior, Animal; Dog Diseases; Dogs; Female; Hair; Masticati | 1978 |
o,p-DDD in the treatment of Cushing's disease.
Topics: Animals; Cushing Syndrome; Dog Diseases; Dogs; Mitotane | 1978 |
The treatment of Cushing's disease in the dog.
Topics: Animals; Cushing Syndrome; Dog Diseases; Dogs; Mitotane | 1976 |
Gamma camera imaging of bilateral adrenocortical hyperplasia and adrenal tumors in the dog.
Topics: 11-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfun | 1976 |
Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic | 1992 |
[Formal pathogenesis, average age and breed distribution in the comparison of 61 Lysodren-treated and 36 untreated cases of canine hyperadrenocorticism which were dissected in the years 1975 to 1991 at the Institute for Veterinary Pathology of the Free Un
Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Age Factors; Animals; Breeding; Cushing Synd | 1992 |
Corticoid production by four dogs with hyperfunctioning adrenocortical tumours during treatment with mitotane (o,p'-DDD).
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Animals; Creatinine; Dog Diseases; Dogs; | 1992 |
[Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
Topics: Adrenocorticotropic Hormone; Alkaline Phosphatase; Animals; Cholesterol; Cushing Syndrome; Dog Disea | 1991 |
Assessment of fat absorption in normal dogs and in dogs with hyperadrenocorticalism.
Topics: Adrenocortical Hyperfunction; Animals; Dietary Fats; Dog Diseases; Dogs; Female; Intestinal Absorpti | 1990 |
Serum protein electrophoresis in spontaneous canine hyperadrenocorticalism.
Topics: Adrenal Cortex Diseases; Alpha-Globulins; Animals; Beta-Globulins; Blood Protein Electrophoresis; Bl | 1989 |
Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
Topics: Adenocarcinoma; Adenoma; Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Mitotane; Pituit | 1989 |
Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
Topics: Adenoma; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Anal Gland Neoplasms; Animals; C | 1988 |
Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
Topics: Adrenal Cortex Function Tests; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; D | 1985 |
An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
Topics: Adrenal Cortex; Adrenocortical Hyperfunction; Animals; Cortisone; Dog Diseases; Dogs; Female; Fludro | 1988 |
Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
Topics: Administration, Oral; Adrenocortical Hyperfunction; Animals; Biological Availability; Dog Diseases; | 1987 |